These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 11896591

  • 21. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC.
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [Abstract] [Full Text] [Related]

  • 22. Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1.
    Prime SS, Eveson JW, Stone AM, Huntley SP, Davies M, Paterson IC, Robinson CM.
    J Pathol; 2004 Aug; 203(4):927-32. PubMed ID: 15258995
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E, Bobik A.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [Abstract] [Full Text] [Related]

  • 25. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L, Hill CS.
    Mol Cell Biol; 2005 Sep 03; 25(18):8108-25. PubMed ID: 16135802
    [Abstract] [Full Text] [Related]

  • 28. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 03; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 29. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS, Ko SG, Kim HP, Kim YB, Lee SY, Kim SG, Jong HS, Kim TY, Lee JW, Bang YJ.
    Int J Oncol; 2004 May 03; 24(5):1229-34. PubMed ID: 15067346
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A, Barna G, Nagy K, Jánosi J, Paku S, Kohut E, Berczi L, Mihalik R, Kopper L.
    Cytokine; 2005 Jun 07; 30(5):228-35. PubMed ID: 15927846
    [Abstract] [Full Text] [Related]

  • 35. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A.
    Oncogene; 2001 Apr 26; 20(18):2205-11. PubMed ID: 11402315
    [Abstract] [Full Text] [Related]

  • 36. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR, Qi L, Higgins PJ.
    J Cell Physiol; 2005 Apr 26; 203(1):156-65. PubMed ID: 15372465
    [Abstract] [Full Text] [Related]

  • 37. Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines.
    Pring M, Prime S, Parkinson EK, Paterson I.
    Int J Oncol; 2006 May 26; 28(5):1279-85. PubMed ID: 16596245
    [Abstract] [Full Text] [Related]

  • 38. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr 26; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 39. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX, Niu ZY, Zhao SL, Smith AJ.
    Arch Oral Biol; 2005 Nov 26; 50(11):929-36. PubMed ID: 16183370
    [Abstract] [Full Text] [Related]

  • 40. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL, Doucet M, Brady K, Weber KL.
    J Bone Miner Res; 2007 Jan 26; 22(1):37-44. PubMed ID: 17032147
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.